BIOLARGO, INC. financial data

Symbol
BLGO on OTC
Location
Westminster, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 216% % -4.9%
Quick Ratio 11% % 73%
Debt-to-equity 70% % 20%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 313,762,657 shares 4.2%
Entity Public Float $61,385,688 USD 50%
Common Stock, Value, Issued $208,000 USD 3%
Weighted Average Number of Shares Outstanding, Basic 308,974,027 shares 2.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $2,726,000 USD 7.6%
Operating Income (Loss) $12,461,000 USD -235%
Nonoperating Income (Expense) $318,000 USD -6500%
Earnings Per Share, Basic 0 USD/shares -1000%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,546,000 USD 17%
Accounts Receivable, after Allowance for Credit Loss, Current $761,000 USD -76%
Inventory, Net $409,000 USD 72%
Assets, Current $5,775,000 USD -22%
Property, Plant and Equipment, Net $1,664,000 USD -7.9%
Operating Lease, Right-of-Use Asset $1,070,000 USD 5%
Other Assets, Noncurrent $116,000 USD 66%
Assets $9,130,000 USD -11%
Accounts Payable, Current $789,000 USD -50%
Employee-related Liabilities, Current $102,000 USD 137%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $3,451,000 USD 7.8%
Operating Lease, Liability, Noncurrent $969,000 USD 2.6%
Liabilities $5,915,000 USD 37%
Accumulated Other Comprehensive Income (Loss), Net of Tax $195,000 USD 15%
Retained Earnings (Accumulated Deficit) $158,327,000 USD -6.6%
Stockholders' Equity Attributable to Parent $6,580,000 USD -23%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3,215,000 USD -46%
Liabilities and Equity $9,130,000 USD -11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,830,000 USD -480%
Net Cash Provided by (Used in) Financing Activities $866,000 USD -20%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 550,000,000 shares 0%
Common Stock, Shares, Issued 311,452,683 shares 3.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $984,000 USD -223%
Interest Paid, Excluding Capitalized Interest, Operating Activities $37,000 USD 208%
Deferred Tax Assets, Valuation Allowance $22,508 USD 1.1%
Operating Lease, Liability $1,111,000 USD 5.9%
Depreciation $154,000 USD 26%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $9,805,000 USD -349%
Lessee, Operating Lease, Liability, to be Paid $1,788,000 USD -2.6%
Property, Plant and Equipment, Gross $2,237,000 USD
Operating Lease, Liability, Current $142,000 USD 35%
Lessee, Operating Lease, Liability, to be Paid, Year Two $335,000 USD 16%
Lessee, Operating Lease, Liability, to be Paid, Year One $384,000 USD 36%
Operating Lease, Weighted Average Discount Rate, Percent 0.18 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $677,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Three $226,000 USD -24%
Deferred Tax Assets, Operating Loss Carryforwards $22,508 USD 1.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $231,000 USD -5.7%
Additional Paid in Capital $164,894,000 USD 5%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense $45,000 USD -47%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%